{"id":65104,"date":"2026-04-24T13:51:10","date_gmt":"2026-04-24T13:51:10","guid":{"rendered":"https:\/\/www.europesays.com\/cz\/65104\/"},"modified":"2026-04-24T13:51:10","modified_gmt":"2026-04-24T13:51:10","slug":"evropa-zaspala-spickova-lecba-rakoviny-zustava-mimo-dosah-milionu-pacientu","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/cz\/65104\/","title":{"rendered":"Evropa zaspala. \u0160pi\u010dkov\u00e1 l\u00e9\u010dba rakoviny z\u016fst\u00e1v\u00e1 mimo dosah milion\u016f pacient\u016f"},"content":{"rendered":"

Radioligandov\u00e9 terapie jsou v sou\u010dasn\u00e9 dob\u011b posledn\u00ed mo\u017enost\u00ed pro pacienty s nejpokro\u010dilej\u0161\u00edm stadiem onkologick\u00e9ho onemocn\u011bn\u00ed. Miliony lid\u00ed v Evrop\u011b k nim st\u00e1le nemaj\u00ed p\u0159\u00edstup. Europoslanec Nikos Papandreou (S&D\/GRC) tla\u010d\u00ed na EU, aby vyu\u017eila sv\u00e9 finan\u010dn\u00ed a regula\u010dn\u00ed pravomoci ke zm\u011bn\u011b. \u201eZdrav\u00ed je pr\u00e1vem, nikoli v\u00fdsadou,\u201c \u0159ekl politik v\u00a0rozhovoru pro EU Perspectives.<\/p>\n

Co v\u00e1s p\u0159im\u011blo zab\u00fdvat se radioligandovou terapi\u00ed?<\/p>\n

O radioligandov\u00e9 terapii jsem se dozv\u011bd\u011bl d\u00edky diskus\u00edm s klinick\u00fdmi l\u00e9ka\u0159i a pacienty. Ale i kv\u016fli \u0161ir\u0161\u00edmu trendu, kter\u00fd v evropsk\u00e9 zdravotn\u00ed politice vid\u00edme opakovan\u011b. Evropa je \u010dasto \u00fasp\u011b\u0161n\u00e1 v inovac\u00edch, ale selh\u00e1v\u00e1 v rovnom\u011brn\u00e9m poskytov\u00e1n\u00ed slu\u017eeb.<\/p>\n

To je zvl\u00e1\u0161t\u011b patrn\u00e9 v nukle\u00e1rn\u00ed medic\u00edn\u011b, kter\u00e1 u\u017e hraje \u00fast\u0159edn\u00ed roli v p\u00e9\u010di o pacienty. Ka\u017ed\u00fd rok se v cel\u00e9 Evrop\u011b prov\u00e1d\u011bj\u00ed miliony z\u00e1krok\u016f, p\u0159esto z\u016fst\u00e1v\u00e1 p\u0159\u00edstup k nejmodern\u011bj\u0161\u00edm terapi\u00edm nerovnom\u011brn\u00fd. Jasn\u011b to ukazuje ned\u00e1vn\u00fd n\u00e1vrh zpr\u00e1vy o rakovin\u011b<\/a> v Evropsk\u00e9m parlamentu. Rozd\u00edly v p\u0159e\u017eit\u00ed, screeningu a p\u0159\u00edstupu k l\u00e9k\u016fm z\u016fst\u00e1vaj\u00ed nap\u0159\u00ed\u010d \u010dlensk\u00fdmi st\u00e1ty i v jejich r\u00e1mci velmi v\u00fdznamn\u00e9<\/p>\n

Radioligandov\u00e9 terapie vy\u017eaduj\u00ed specializovanou infrastrukturu a pracovn\u00ed s\u00edlu. Kdo by to m\u011bl \u0159\u00eddit: \u010dlensk\u00e9 st\u00e1ty nebo EU?<\/p>\n

\u010clensk\u00e9 st\u00e1ty organizuj\u00ed zdravotn\u00ed p\u00e9\u010di, ale u vysoce specializovan\u00fdch terapi\u00ed, jako je l\u00e9\u010dba radioligandy, \u010dist\u011b vnitrost\u00e1tn\u00ed \u0159e\u0161en\u00ed nesta\u010d\u00ed.<\/p>\n

Z m\u00e9ho pohledu je zdrav\u00ed pr\u00e1vem, nikoli v\u00fdsadou. Pokud p\u0159\u00edstup k\u00a0p\u00e9\u010di z\u00e1vis\u00ed na tom, kde \u010dlov\u011bk \u017eije, m\u00e1 EU povinnost pom\u00e1hat tuto nerovnost sn\u00ed\u017eit prost\u0159ednictv\u00edm koordinace, investic a podpory infrastruktury a dovednost\u00ed. Radioligandov\u00e9 terapie jsou toho jasn\u00fdm p\u0159\u00edkladem, zejm\u00e9na u l\u00e9ka\u0159sk\u00fdch radioizotop\u016f, kter\u00e9 nelze efektivn\u011b vyv\u00edjet izolovan\u011b.<\/p>\n

Kapacity odborn\u00fdch center by se podle v\u00e1s m\u011bly organizovat prost\u0159ednictv\u00edm evropsk\u00fdch referen\u010dn\u00edch s\u00edt\u00ed (ERN). Jak by to m\u011blo vypadat v praxi?<\/p>\n

Jsem pro siln\u011bj\u0161\u00ed podporu EU centr\u016fm excelence, propojen\u00fdch prost\u0159ednictv\u00edm ERN, s jasn\u011bj\u0161\u00edmi postupy p\u0159i p\u0159ed\u00e1v\u00e1n\u00ed pacient\u016f a praktickou podporou pro pacienty a rodiny v\u00a0p\u0159\u00edpadech p\u0159eshrani\u010dn\u00ed l\u00e9\u010dby. Ne ka\u017ed\u00e1 zem\u011b m\u016f\u017ee nebo by m\u011bla budovat v\u0161echny kapacity sama.<\/p>\n

I v tomto ohledu je n\u00e1vrh zpr\u00e1vy o rakovin\u011b u\u017eite\u010dn\u00fd. Uv\u00e1d\u00ed, \u017ee evropsk\u00e9 referen\u010dn\u00ed s\u00edt\u011b jsou pro vz\u00e1cn\u00e9 druhy rakoviny nezbytn\u00e9, ale \u017ee p\u0159eshrani\u010dn\u00ed postupy p\u0159i p\u0159ed\u00e1v\u00e1n\u00ed pacient\u016f nejsou dostate\u010dn\u011b vyu\u017e\u00edvan\u00e9. Vyz\u00fdv\u00e1 k trval\u00fdm investic\u00edm, aby m\u011bl ka\u017ed\u00fd pacient p\u0159\u00edstup k multidisciplin\u00e1rn\u00ed odbornosti.<\/p>\n

Nazna\u010dil jste, \u017ee jakmile Evropsk\u00e1 agentura pro l\u00e9\u010div\u00e9 p\u0159\u00edpravky (EMA) schv\u00e1l\u00ed l\u00e9\u010dbu, m\u011bla by b\u00fdt automaticky p\u0159ijata na vnitrost\u00e1tn\u00ed \u00farovni. Vyz\u00fdv\u00e1te tedy k ukon\u010den\u00ed duplicity vnitrost\u00e1tn\u00edho propl\u00e1cen\u00ed a posuzov\u00e1n\u00ed?<\/p>\n

Nevyz\u00fdv\u00e1m k odstran\u011bn\u00ed pravomoc\u00ed \u010dlensk\u00fdch st\u00e1t\u016f, ale ke sn\u00ed\u017een\u00ed zbyte\u010dn\u00fdch prodlev. P\u0159\u00edli\u0161 \u010dasto se st\u00e1v\u00e1, \u017ee l\u00e9\u010dba m\u016f\u017ee b\u00fdt v\u011bdecky ov\u011b\u0159ena na evropsk\u00e9 \u00farovni, ale pacienti pot\u00e9 st\u00e1le \u010del\u00ed rozt\u0159\u00ed\u0161t\u011bn\u00fdm a pomal\u00fdm p\u0159\u00edstupov\u00fdm cest\u00e1m.<\/p>\n

Pot\u0159ebujeme lep\u0161\u00ed koordinaci mezi EMA, procesy HTA a vnitrost\u00e1tn\u00edmi syst\u00e9my, v\u011bt\u0161\u00ed transparentnost lh\u016ft a m\u00e9n\u011b zdvojov\u00e1n\u00ed tam, kde u\u017e do\u0161lo k\u00a0d\u016fkladn\u00e9mu posouzen\u00ed d\u016fkaz\u016f. C\u00edl je jednoduch\u00fd: Inovace schv\u00e1len\u00e9 v Evrop\u011b by se m\u011bly k pacient\u016fm dostat rychleji a spravedliv\u011bji.<\/p>\n

Mohlo by v\u00e1s zaj\u00edmat<\/p>\n


\n \"\"
\n <\/a><\/p>\n

Financov\u00e1n\u00ed EU se podle v\u00e1s st\u00e1le v\u00edce orientuje na v\u00fdsledky. To je ale v medic\u00edn\u011b obt\u00ed\u017en\u00e9. Jak by m\u011bly projekty v oblasti zdrav\u00ed prokazovat \u201ev\u00fdsledky\u201c?<\/p>\n

Pot\u0159ebujeme \u0161ir\u0161\u00ed a realisti\u010dt\u011bj\u0161\u00ed ch\u00e1p\u00e1n\u00ed v\u00fdsledk\u016f ve zdravotnictv\u00ed. P\u0159e\u017eit\u00ed je samoz\u0159ejm\u011b d\u016fle\u017eit\u00e9, ale stejn\u011b tak i kvalita \u017eivota, v\u010dasn\u011bj\u0161\u00ed diagnostika, zkr\u00e1cen\u00ed \u010dekac\u00edch dob a to, zda se l\u00e9\u010dba skute\u010dn\u011b dostane k pacient\u016fm ve v\u0161ech \u010dlensk\u00fdch st\u00e1tech.<\/p>\n

To je tak\u00e9 d\u016fvod, pro\u010d se domn\u00edv\u00e1m, \u017ee p\u0159\u00ed\u0161t\u00ed f\u00e1ze zdravotn\u00ed politiky EU se mus\u00ed zam\u011b\u0159it nejen na objevy, ale i na jejich realizaci. Evropa nepot\u0159ebuje jen inovovat, mus\u00ed se zorganizovat tak, aby se inovace prom\u00edtly do spravedliv\u00e9ho p\u0159\u00edstupu.<\/p>\n

\u010cl\u00e1nek byl p\u0159evzat\u00fd ze zpravodajsk\u00e9ho port\u00e1lu EU Perspectives, kter\u00fd stejn\u011b jako Zdravotnick\u00fd den\u00edk, Ekonomick\u00fd den\u00edk a \u010cesk\u00e1 justice pat\u0159\u00ed do vydavatelstv\u00ed Media Network.<\/p>\n","protected":false},"excerpt":{"rendered":"Radioligandov\u00e9 terapie jsou v sou\u010dasn\u00e9 dob\u011b posledn\u00ed mo\u017enost\u00ed pro pacienty s nejpokro\u010dilej\u0161\u00edm stadiem onkologick\u00e9ho onemocn\u011bn\u00ed. Miliony lid\u00ed v…\n","protected":false},"author":2,"featured_media":65105,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[109,108,106,571,22172,22173,22174,22175,22176,22177,22178,2811],"class_list":{"0":"post-65104","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-evropa","8":"tag-europa","9":"tag-europe","10":"tag-evropa","11":"tag-evropska-unie","12":"tag-evropske-referencni-site","13":"tag-evropske-zdravotnictvi","14":"tag-moderni-lecba","15":"tag-nerovnosti-v-lecbe","16":"tag-nikos-papandreou","17":"tag-onkologicka-onemocneni","18":"tag-radioligandova-terapie","19":"tag-rakovina"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@cz\/116460013907311841","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/posts\/65104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/comments?post=65104"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/posts\/65104\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/media\/65105"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/media?parent=65104"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/categories?post=65104"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/tags?post=65104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}